← Back to Search

Active scheduling for Lazy Eye

N/A
Waitlist Available
Led By Andrew J Schuman
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All pediatrics patients without pre-existing vision problems undergoing instrument vision screening at DH Pediatric CGP Clinics in at ages 2,3,4,5, and 6 years of age.
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 1 year
Awards & highlights

Study Summary

This trial is testing a new referral and tracking system for amblyopia and pre-amblyopic strabismus in children. The hope is that this system will lead to more children being treated for these conditions.

Eligible Conditions
  • Lazy Eye
  • Vision Screening

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of children who complete vision evaluation
Secondary outcome measures
Number of children with amblyopia or pre amblyopic strabismus identified and treated

Trial Design

1Treatment groups
Experimental Treatment
Group I: Active schedulingExperimental Treatment1 Intervention
Children who fail instrument vision screens will be scheduled at a community vision specialist office before departure from clinic and all no shows at the vision specialist office will be tracked and rescheduled.

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor
524 Previous Clinical Trials
2,543,341 Total Patients Enrolled
Andrew J SchumanPrincipal InvestigatorDartmouth-Hitchcock Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Assuring Ophthalmologic Follow up
Andrew J. Schuman 2023. "Assuring Ophthalmologic Follow up". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04959422.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top